Mostrar el registro sencillo del objeto digital

dc.contributor.author TENORIO BORROTO, ESVIETA
dc.contributor.author PEÑUELAS RIVAS, CLAUDIA GIOVANNA
dc.contributor.author VAZQUEZ CHAGOYAN, JUAN CARLOS
dc.contributor.author Castañedo Cancio, Nilo Ramón
dc.contributor.author PRADO PRADO, FRANCISCO JAVIER
dc.contributor.author Garcia-Mera, Xerardo
dc.contributor.author GONZALEZ DIAZ, HUMBERTO
dc.creator TENORIO BORROTO, ESVIETA; 335911
dc.creator PEÑUELAS RIVAS, CLAUDIA GIOVANNA; 213291
dc.creator VAZQUEZ CHAGOYAN, JUAN CARLOS; 120705
dc.creator Castañedo Cancio, Nilo Ramón;x1343062
dc.creator PRADO PRADO, FRANCISCO JAVIER; 493894
dc.creator Garcia-Mera, Xerardo;#0000-0001-5218-6351
dc.creator GONZALEZ DIAZ, HUMBERTO;x1342236
dc.date.accessioned 2018-03-13T01:00:59Z
dc.date.available 2018-03-13T01:00:59Z
dc.date.issued 2014-01-05
dc.identifier.issn 0223-5234
dc.identifier.uri http://hdl.handle.net/20.500.11799/79879
dc.description Modelos matematicos y citometria es
dc.description.abstract Quantitative Structure-Activity (mt-QSAR) techniques may become an important tool for prediction of cytotoxicity and High-throughput Screening (HTS) of drugs to rationalize drug discovery process. In this work, we train and validate by the first time mt-QSAR model using TOPS-MODE approach to calculate drug molecular descriptors and Linear Discriminant Analysis (LDA) function. This model correctly classifies 8,258 out of 9,000 (Accuracy = 91.76%) multiplexing assay endpoints of 7903 drugs (including both train and validation series). Each endpoint correspond to one out of 1418 assays, 36 molecular and cellular targets, 46 standard type measures, in two possible organisms (human and mouse). After that, we determined experimentally, by the first time, the values of EC50 = 21.58 μg/mL and Cytotoxicity = 23.6 % for the anti-microbial / antiparasite drug G1 over Balb/C mouse peritoneal macrophages using flow cytometry. In addition, the model predicts for G1 only 7 positive endpoints out 1,251 cytotoxicity assays (0.56% of probability of cytotoxicity in multiple assays). The results obtained complement the toxicological studies of this important drug. This work adds a new tool to the existing pool of few methods useful for multi-target HTS of ChEMBL and other libraries of compounds towards drug discovery. es
dc.description.sponsorship Conacyt es
dc.language.iso eng es
dc.publisher European Journal of Medicinal Chemistry es
dc.relation.ispartofseries 24;
dc.rights openAccess es
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0
dc.subject Flow cytometry es
dc.subject High-throughput model es
dc.subject Drug immunotoxicity es
dc.subject Multiplex assay endpoints es
dc.subject.classification MEDICINA Y CIENCIAS DE LA SALUD
dc.title Model for High-Throughput Screening of drug immunotoxicity - study of the antimicrobial G1 over peritoneal macrophages using flow cytometry es
dc.type Artículo es
dc.provenance Científica es
dc.road Dorada es
dc.organismo Medicina Veterinaria y Zootecnia es
dc.ambito Internacional es
dc.cve.CenCos 21401 es
dc.cve.progEstudios 2 es
dc.audience students
dc.audience researchers
dc.type.conacyt article
dc.identificator 3


Ficheros en el objeto digital

Este ítem aparece en la(s) siguiente(s) colección(ones)

Visualización del Documento

  • Título
  • Model for High-Throughput Screening of drug immunotoxicity - study of the antimicrobial G1 over peritoneal macrophages using flow cytometry
  • Autor
  • TENORIO BORROTO, ESVIETA
  • PEÑUELAS RIVAS, CLAUDIA GIOVANNA
  • VAZQUEZ CHAGOYAN, JUAN CARLOS
  • Castañedo Cancio, Nilo Ramón
  • PRADO PRADO, FRANCISCO JAVIER
  • Garcia-Mera, Xerardo
  • GONZALEZ DIAZ, HUMBERTO
  • Fecha de publicación
  • 2014-01-05
  • Editor
  • European Journal of Medicinal Chemistry
  • Tipo de documento
  • Artículo
  • Palabras clave
  • Flow cytometry
  • High-throughput model
  • Drug immunotoxicity
  • Multiplex assay endpoints
  • Los documentos depositados en el Repositorio Institucional de la Universidad Autónoma del Estado de México se encuentran a disposición en Acceso Abierto bajo la licencia Creative Commons: Atribución-NoComercial-SinDerivar 4.0 Internacional (CC BY-NC-ND 4.0)

Mostrar el registro sencillo del objeto digital

openAccess Excepto si se señala otra cosa, la licencia del ítem se describe cómo openAccess

Buscar en RI


Buscar en RI

Usuario

Estadísticas